Moreover, lipotecan remarkably with radiotherapy enhances TAP1 and MHC class I expression for antigen presentation, reinvigorating cancer immunogenicity for tumor-specific T cell activation and leading to favorable complete regression ability in vitro and in vivo. This evidence concerns the gene TAP1 and cancer.